Renaissance Capital logo

ALVR News

US IPO Week Ahead: Chinese EV's billion-dollar deal closes out summer in a 2 IPO week

XPEV

Two IPOs and two SPACs are scheduled to go public in the week ahead. Chinese EV maker Xpeng (XPEV) is leading summer's last wave with a billion-dollar deal. Xpeng (XPEV) plans to raise $1.0 billion at an $8.8 billion market cap....read more

US IPO Weekly Recap: Vital Farms pops 60% in a 7 IPO week

ALVR

Seven IPOs and five SPACs entered the public markets this week led by top performer Vital Farms (VITL), which popped 60% in its public debut. Vital Farms (VITL), the largest US producer of pasture-raised eggs, upsized and priced above...read more

Viral disease biotech AlloVir prices upsized IPO at $17 midpoint

AlloVir logo

AlloVir, a Phase 2 biotech developing allogeneic T cell therapies for viral diseases, raised $276 million by offering 16.3 million shares at $17, the midpoint of the range of $16 to $18. The company offered 1.5 million more shares than anticipated. At pricing,...read more

US IPO Week Ahead: Chinese EVs and US tax software lead a diverse 7 IPO week

VERX

Seven IPOs and one SPAC plan to raise $2.1 billion in the week ahead, led by tax software provider Vertex (VERX). A handful of companies could join the IPO calendar in the coming week, including leading mortgage lender Rocket Companies...read more